Showing results (381-390 of 448) with videos related to
Sort By:
Pageof 45
Scientific Reports|January 28, 2022
Upregulated heme biosynthesis increases obstructive sleep apnea severity: a pathway-based Mendelian randomization studyHeming Wang, Nuzulul Kurniansyah, Brian E Cade, et al.Human Molecular Genetics|November 1, 2016
Variants in angiopoietin-2 (ANGPT2) contribute to variation in nocturnal oxyhaemoglobin saturation levelHeming Wang, Brian E Cade, Han Chen, et al.Stroke|July 2, 2015
Proteinuria, but Not eGFR, Predicts Stroke Risk in Chronic Kidney Disease: Chronic Renal Insufficiency Cohort StudyDanielle K Sandsmark, Steven R Messé, Xiaoming Zhang, et al.Ebiomedicine|June 4, 2018
Multi-Omics Analysis Reveals a HIF Network and Hub Gene EPAS1 Associated with Lung AdenocarcinomaZhaoxi Wang, Yongyue Wei, Ruyang Zhang, et al.Nature|April 15, 2026
EBV strain interacts with host HLA to drive nasopharyngeal carcinoma riskYanhong Chen, Jingtong Liang, Wanlin Zhang, et al.EMBO Molecular Medicine|January 22, 2025
FABP4 as a therapeutic host target controlling SARS-CoV-2 infectionHatoon Baazim, Emre Koyuncu, Gürol Tuncman, et al.American Journal of Hypertension|April 27, 2017
Racial/Ethnic Differences in Left Ventricular Structure and Function in Chronic Kidney Disease: The Chronic Renal Insufficiency CohortFaraz S Ahmad, Xuan Cai, Katherine Kunkel, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 1, 2020
Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) StudyAmanda H Anderson, Dawei Xie, Xue Wang, et al.Infection|November 26, 2025
Live microbials to boost Anti-SARS-CoV-2 immunity clinical trial (Live BASIC trial): a triple-blind randomized controlled trialDaniel B Horton, Rahul Ukey, Abhilasha Madhvi, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 12, 2023
Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLCJoao V Alessi, Arielle Elkrief, Biagio Ricciuti, et al.Pageof 45